Carsten Rickers

Carsten Rickers

Auto-generated profile, based on publicly available information

Carsten Rickers

Department of Congenital Heart Disease and Pediatric Cardiology , University Hospital of Schleswig-Holstein , Kiel , Germany

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
IVInga Voges
Inga Voges
MJMichael Jerosch-Herold
Michael Jerosch-Herold
JHJürgen Hedderich
Jürgen Hedderich
EPEileen Pardun
Eileen Pardun
CHChristopher Hart
Christopher Hart
CRCarsten Rickers
Carsten Rickers
Aortic enlargement and impaired bioelasticity are of interest in several cardiac and non-cardiac diseases as they can lead to cardiovascular complications. Cardiovascular magnetic resonance (CMR) is increasingly accepted as a noninvasive tool in cardiovascular evaluation. Assessment of aortic anatomy and bioelasticity, namely aortic distensibility and pulse wave velocity (PWV), by CMR is accurate and reproducible and could help to identify anatomical and bioelastic abnormalities of the aorta. However, normal CMR values for healthy children and young adults are lacking.

30 June 2013 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
IVInga Voges
Inga Voges
JBJan H. Bräsen
Jan H. Bräsen
AEAndreas Entenmann
Andreas Entenmann
MSMichael Scheid
Michael Scheid
JSJens Scheewe
Jens Scheewe
CRCarsten Rickers
Carsten Rickers
Matrix P® and Matrix P plus® tissue-engineered pulmonary valves (TEPV) were offered as an improvement for pulmonary valve replacement (PVR) because of recellularization by host cells. The high frequency of graft failure gave reason to evaluate the underlying morphological substrate using magnetic resonance imaging (MRI) and histology. Between June 2006 and August 2008, 17 Matrix P® and 10 Matrix P plus® TEPVs were implanted in 26 patients with a median age of 12.4 (range: 0.8–38.7, interquartile range: 6.1–18.1) years. The grafts were studied by MRI, and underwent histological examination when explantation was required. Surgical (n = 13) or transcatheter (n = 1) TEPV replacement because of graft failure was needed in 14 cases (52%) 19 (0.5–53) months after implantation. MRI detected significant TEPV stenosis with mild insufficiency (Vmax = 3.7 ± (standard deviation) 0.5 m/s, regurgitant fraction (RGF) = 10 ± 3%) and stenosis with moderate-to-severe insufficiency (Vmax = 3.5 ± 0.8 m/s, RGF = 38 ± 10%) in 6 patients, respectively, and severe insufficiency (RGF = 40%) in 1 patient. In patients with graft failure, MRI showed hyperenhancement and TEPV wall thickening. Histology revealed severe inflammation, increased fibrous tissue and foreign-body reaction against valve leaflets and fascial tissue, while TEPV endothelialization was not detected in any case. The high frequency of Matrix P® and Matrix P plus® graft failure can be related to inflammation and fibrosis revealed by MRI and histology. Our results do not support the use of these valves for PVR and suggest careful follow-up examinations, including MRI for early detection of graft inflammation and fibrosis.

1 January 2016 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
IVInga Voges
Inga Voges
JKJulian Kees
Julian Kees
MJMichael Jerosch-Herold
Michael Jerosch-Herold
HGHannes Gottschalk
Hannes Gottschalk
JTJens Trentmann
Jens Trentmann
CRCarsten Rickers
Carsten Rickers
The increased cardiovascular morbidity of adults with late repair of aortic coarctation (CoA) has been well documented. In contrast, successful CoA repair in early childhood has a generally good prognosis, though adverse vascular and ventricular characteristics may be abnormal, which could increase long-term risk. This study sought to perform a comprehensive analysis of aortic elasticity and left ventricular (LV) function in patients with aortic coarctation (CoA) using cardiovascular magnetic resonance (CMR). In a subgroup of patients, we assessed structure and function of the common carotid arteries to probe for signs of systemic vascular remodeling. Fifty-one patients (median age 17.3 years), 13.9 ± 7.5 years after CoA repair, and 54 controls (median age 19.8 years) underwent CMR. We determined distensibility and pulse wave velocity (PWV) at different aortic locations. In a subgroup, common carotid artery distensibility, PWV, wall thickness and wall area were measured. LV ejection fraction (EF), volumes, and mass were measured from short axis views. Left atrial (LA) volumes and functional parameters (LAEFPassive, LAEFContractile, LAEFReservoir) were assessed from axial cine images. In patients distensibility of the whole thoracic aorta was reduced (p < 0.05) while PWV was only significantly higher in the aortic arch (p < 0.01). Distensibility of the descending aorta at the level of the pulmonary arteries and PWV in the descending aorta, both correlated negatively with age at CoA repair. LA volume before atrial contraction and minimal LA volume were higher in patients (p < 0.05). LAEFPassive and LAEFReservoir were reduced (p < 0.05), and LAEFReservoir correlated negatively with aortic arch PWV (p < 0.05). LVEF, volumes and mass were not different from controls. Carotid wall thickness and PWV were higher in patients compared to controls (p < 0.05). Patients after CoA repair have impaired bioelastic properties of the thoracic aorta with impact on LV diastolic function. Reduced descending aortic elasticity is associated with older age at time of CoA repair. The remodeling of the common carotid artery in our sub-study suggests systemic vessel wall changes.

27 October 2015 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
IVInga Voges
Inga Voges
MJMichael Jerosch‐Herold
Michael Jerosch‐Herold
PWPhilip Wegner
Philip Wegner
CHChristopher Hart
Christopher Hart
DGDominik Gabbert
Dominik Gabbert
CRCarsten Rickers
Carsten Rickers
Background: Patients with hypoplastic left heart syndrome after a Norwood operation show dilatation and reduced distensibility of the reconstructed proximal aorta. Cardiac magnetic resonance imaging ( CMR ) and angiographic examinations indicate that the native descending aorta ( DA o) is also dilated, but this has not been studied in detail. Methods and Results: Seventy‐nine children with hypoplastic left heart syndrome in Fontan circulation (aged 6.3±3.2 years) and 18 control participants (aged 6.8±2.4 years) underwent 3.0‐tesla CMR . Gradient‐echo cine and phase‐contrast imaging was applied to measure cross‐sectional areas ( CSA s), distensibility, pulse wave velocity, and the incremental elastic modulus of the thoracic aorta. CSA of the DA o in patients was also compared with published percentiles for aortic CSA . Patients had significantly larger CSA of the DA o at the level of pulmonary artery bifurcation (229.1±97.2 versus 175.7±24.3 mm/m 2 , P =0.04) and the diaphragm (196.2±66.0 versus 142.6±16.7 mm/m 2 , P <0.01). In 41 patients (52%), CSA of the DA o was >95th percentile level for control participants, and the incremental elastic modulus of the aortic arch and the DA o was higher than in patients with normal CSA s (arch: 90.1±64.3 versus 45.6±38.9 m/s; DA o: 86.3±53.7 versus 47.1±47.6 m/s; P <0.01). Incremental elastic modulus of the aortic arch and the DA o correlated with the CSA of the DA o (arch: r =0.5; DA o: r =0.49; P <0.01). Conclusions: Children with hypoplastic left heart syndrome frequently show dilatation of their DA o associated with increased stiffness of the aortic arch. Higher aortic impedance increases the afterload of the systemic circulation and likely contributes to the burden of the systemic right ventricle.

27 February 2013 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
IVInga Voges
Inga Voges
MJMichael Jerosch-Herold
Michael Jerosch-Herold
CHChristopher Hart
Christopher Hart
JSJens Scheewe
Jens Scheewe
DGDominik Daniel Gabbert
Dominik Daniel Gabbert
CRCarsten Rickers
Carsten Rickers
In patients after completion of the total cavopulmonary connection (TCPC) with an intra-atrial lateral tunnel, deviations of the tunnel from an ideal straight tubular shape were observed. However, little is known about frequency and adverse effects of such shape deviations. We sought to analyse tunnel anatomy, dimensions and blood flow using cardiac magnetic resonance imaging (CMR). Fifty-four patients with hypoplastic left heart syndrome (HLHS; mean age 6.0 ± 2.4 years) underwent CMR with gradient-echo cine sequences, 2D- and 3D-phase-contrast imaging. We analysed anatomy, diameters, cross-sectional areas, volumes and blood flow of the tunnel. Twenty-five patients had a tubular tunnel. In 29 patients, bulging and/or narrowing of the tunnel were present. Cross-sectional areas and volumes of the tunnel were not significantly different between the two groups. There were also no differences for the mean blood flow and the mean and maximal flow velocity (P = 0.05–0.6). In all the patients, the normalized tunnel volume was related to age (r = 0.44; P = 0.002) and body surface area (BSA; r = 0.42; P = 0.005). The mean tunnel blood flow correlated with age (r = 0.73; P = 0.001) and BSA (r = 0.83; P < 0.0001). A considerable percentage of patients with an intra-atrial lateral tunnel develop mild deviations of the tunnel from ideal tubular shape. The correlation between tunnel volume and mean blood flow with age and BSA suggests that the capacity of the tunnel adjusts to body growth, independent of tunnel shapes that deviate from a fluid-dynamically favourable shape. Follow-up CMRs are needed to detect long-term effects of irregular tunnel shapes on flow dynamics.

26 May 2017 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
JLJana Logoteta
Jana Logoteta
LDLars Dullin
Lars Dullin
JHJan Hinnerk Hansen
Jan Hinnerk Hansen
CRCarsten Rickers
Carsten Rickers
MRMona Salehi Ravesh
Mona Salehi Ravesh
HKHans-Heiner Kramer
Hans-Heiner Kramer
OBJECTIVES: Since 1996, our centre performs restrictive enlargement of the pulmonary annulus at surgical repair of tetralogy of Fallot. A transannular patch is only used if the z-score of the pulmonary annulus is smaller than −2. We sought to determine whether this strategy reduces pulmonary insufficiency (PI) and reoperation rate compared to a nationwide contemporary cohort that has not been operated using a uniform strategy. METHODS: Eighty-seven tetralogy of Fallot patients were included in the study (Group 1). One hundred sixty-seven tetralogy of Fallot patients from the Competence Network for Congenital Heart Disease served as controls (Group 2). Clinical, echocardiographic, electrocardiogram, cardiovascular magnetic resonance and outcome data were analysed. RESULTS: Follow-up time since repair was not different between groups [12.9 (7.8–18.8) vs 13.1 (5.2-16.9) years, P = 0.96] while transannular patch rate was significantly lower in Group 1 (32.2% vs 64.7%, P < 0.001). Ten-year freedom from reoperation for PI was significantly higher in our cohort (98% vs 92%, P = 0.01). Multivariable analysis identified restrictive enlargement as the only predictor for no need of reoperation [hazard ratio 0.4 (95% confidence interval 0.24–0.84), P < 0.01]. In Group 1, cardiovascular magnetic resonance-derived volumes were smaller (indexed end-diastolic volume: 103 ± 24 vs 123 ± 31 ml/m2, P < 0.001; indexed end-systolic volume: 53 ± 19 vs 59 ± 20 ml/m2, P = 0.04) and regurgitation fraction was lower (21 ± 14 vs 31 ± 17%, P < 0.001). CONCLUSIONS: Restrictive enlargement of the pulmonary annulus reduces PI and limits the amount of right ventricular dilatation at intermediate-term follow-up. The need for reoperation to alleviate PI is significantly lower compared to a contemporary cohort. Restrictive enlargement strategy has a stronger influence on freedom from reoperation than the use of a transannular patch. Clinical Trial Registration: WHO Main ID: DRKS00010087. URL: http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00010087.